| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |